NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT06013423 2026-01-22Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesFred Hutchinson Cancer CenterPhase 2 Recruiting54 enrolled
NCT05031897 2025-10-30Two Step Haplo With Radiation ConditioningThomas Jefferson UniversityPhase 2 Recruiting63 enrolled